[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"head-pain\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:head-pain":79},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,49],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":48},"100604868",false,"NCT07155109","Different Intraperitoneal Pressures on Optic Nerve Sheath Diameter in Laparoscopic Surgeries","The Effects of Different Intraperitoneal Pressures on Optic Nerve Sheath Diameter in Laparoscopic Gyneco-oncologic Surgeries","Inclusion Criteria:\n\n* Laparoscopic gyneco-oncological surgeries\n* Female patients aged 18-65 years\n* ASA physical status classification I-II-III patients\n\nExclusion Criteria:\n\n* Patients with diabetic retinopathy\n* Patients with glaucoma\n* Patients with cerebrovascular disease\n* Pregnant women\n* Patients with known allergy to anaesthetic agents\n* Morbidly obese patients with BMI \\> 40",true,"FEMALE","18 Years","65 Years",{"count":20,"type":21},100,"ESTIMATED","INTERVENTIONAL",[24],"NA","The aim of this study is to investigate the effects of low and normal intraperitoneal pressures on intraoperative optic nerve sheath diameter in laparoscopic gyneco-oncologic surgeries.",[27,28,29],"Intracranial Pressure Increase","Abdominal Pain","Head Pain",[31,32,33,34,35],"Intracranial Pressure","optic nerve","laparascopy","gyneco-oncologic surgery","low pressure","NOT_YET_RECRUITING","2025-08-27",{"date":39,"type":40},"2025-09-04","ACTUAL",{"date":42,"type":21},"2025-08-30",{"date":44,"type":21},"2025-10-20",{"name":46,"class":47},"Diskapi Yildirim Beyazit Education and Research Hospital","OTHER_GOV",1,{"id":50,"slug":4,"hasResults":10,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":4,"eligibilityCriteria":54,"healthyVolunteers":10,"sex":55,"minAge":17,"maxAge":56,"enrollmentInfo":57,"targetDuration":4,"studyType":22,"phases":59,"briefSummary":52,"conditions":61,"keywords":62,"overallStatus":68,"whyStopped":4,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":48},"100464275","NCT05325580","Intravenous Magnesium Sulfate Vs Placebo to Treat Non -Traumatic Acute Headaches in the Emergency Department","Intravenous Magnesium Sulfate Vs Placebo to Treat Non-traumatic Acute Headaches in the Emergency Department","Inclusion Criteria:\n\n* informed consent\n* age \\>18 years\n* Acute non-traumatic acute headaches\n* patients treated in ED\n* Magnesium sulfate and aspirin administered intravenously (IV)\n\nExclusion Criteria:\n\n* Current regular use of analgesics, anticonvulsants or antidepressants\n* Renal disorder with a low glomerular filtration rate (\\\u003C60 ml\u002Fmin)\n* Neuromuscular disorder\n* Pregnant woman\n* Contrindication\n* Allergy to NSAID\n* Traumatic Headache\n* Chronic headache ( headache occurring at least 15 days per month for at least 3 months)\n* Hemodynamic instability","ALL","85 Years",{"count":58,"type":21},424,[60],"PHASE3",[29],[63,64,65,66,67],"intavenous","magnesium sulfate","nontraumatic","acute headaches","placebo","RECRUITING","2024-02-27",{"date":71,"type":40},"2024-02-28",{"date":73,"type":40},"2021-12-01",{"date":75,"type":21},"2026-12-30",{"name":77,"class":78},"University of Monastir","OTHER",""]